Tenpoint Therapeutics

Tenpoint Therapeutics is a biotechnology company dedicated to advancing cell-based engineered therapies and in vivo reprogramming to restore vision for patients with degenerative eye diseases, bringing together global experts shaping the revolution in regenerative ophthalmology and the technologies driving it. The company is addressing the root causes of vision loss by permanently restoring vision through the replacement of diseased cells with healthy ones. Tenpoint’s global team is united by our passion for science and commitment to patients.